(S)-4-(TERT-BUTOXYCARBONYL)-1,4-OXAZEPANE-2-CARBOXYLIC ACID, 95.0%, 250mg

4-Chlorothieno[3,2-d]pyrimidine-6-carboxylic acid, 95.0%, 5g

4-(2-Keto-1-benzimidazolinyl)piperidine, 95.0%, 5g

Diisopropyl fumarate, 95.0%, 25g

Ethyl 4-hydroxycyclohexanecarboxylate, 95.0%, 1g

2-CHLORO-3-(1,3-DITHIAN-2-YL)PYRAZINE, 95.0%, 1g

2',7'-Dichlorofluorescein Sodium Salt>98.0%(T)1g

(diazyn-1-ium-1-yl)[2-(2-hydroxyethoxy)ethyl]azanide, 97%, 250mg

methyl (1S,3R,4R)-3-{[(tert-butoxy)carbonyl]amino}-4-hydroxycyclopentane-1-carboxylate, 95.0%, 500mg

1-ethyl-4,5-dihydro-1H-1,2,3,4-tetrazole-5-thione, 98%, 100mg

1-Methoxy-4-(prop-1-en-2-yl)benzene, 95+%, 5g

Sample tub, 150 ml, Non-sterile, 120 Piece(s)

2,3-Dihydro-1H-cyclopenta[b]quinolin-9-ylamine, 97.0%, 5g